聯合治療公司
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionMorgan Stanley
Latest Disclosed Ownership409,288 shares
Latest Disclosed Value $ 242,700,645
Morgan Stanley reports 5.14% increase in ownership of UTHR / United Therapeutics Corporation

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 409,288 shares of United Therapeutics Corporation (US:UTHR) valued at $242,699,598 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 389,275 shares of United Therapeutics Corporation. This represents a change in shares of 5.14% during the quarter. The current value of the position is $225,055,193 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 409,288 20,013 5.14 242,701 27.96 0.0146
2026-05-27 2025-12-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 389,275 -49,529 -11.29 189,675 3.11 0.0113
2026-02-13 2025-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 389,275 -49,529 189,675 0.0113
2026-05-27 2025-09-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 438,804 41,290 10.39 183,952 61.04 0.0111
2025-11-14 2025-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 438,804 41,290 183,952 0.0111
2025-08-15 2025-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 397,514 -23,281 -5.53 114,226 -11.94 0.0074
2025-05-15 2025-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 420,795 9,043 2.20 129,719 -10.71 0.0093
2025-05-15 2024-12-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 411,752 10,289 2.56 145,283 0.99 0.0102
2025-02-14 2024-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 411,752 10,289 145,283 0.0102
2025-05-14 2024-09-30 13F/A-2 UNITED THERAPEUTICS CORP DEL COM 91307C102 401,463 -405,525 -50.25 143,865 -44.04 0.0104
2025-02-14 2024-09-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 401,463 -405,525 143,865 0.0104
2024-11-14 2024-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 401,463 -405,525 143,865 0.0012
2025-05-14 2024-06-30 13F/A-2 UNITED THERAPEUTICS CORP DEL COM 91307C102 806,988 270,780 50.50 257,066 108.70 0.0199
2024-10-17 2024-06-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 806,988 270,780 257,066 0.0199
2024-08-14 2024-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 806,988 270,780 257,066 0.0199
2024-10-17 2024-03-31 13F/A-2 UNITED THERAPEUTICS CORP DEL COM 91307C102 536,208 76,476 16.63 123,178 21.85 0.0099
2024-08-16 2024-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 536,208 76,476 123,178 0.0012
2024-05-15 2024-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 536,208 76,476 123,178 0.0099
2024-08-16 2023-12-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 459,732 105,331 29.72 101,091 26.29 0.0089
2024-02-13 2023-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 459,732 105,331 101,091 0.0089
2023-11-15 2023-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 354,401 45,625 14.78 80,049 17.44 0.0081
2023-08-14 2023-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 308,776 -34,116 -9.95 68,163 -11.24 0.0067
2023-05-15 2023-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 342,892 -45,913 -11.81 76,794 -28.97 0.0082
2023-02-14 2022-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 388,805 132,795 51.87 108,123 101.70 0.0123
2022-11-14 2022-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 256,010 -89,313 -25.86 53,605 -34.12 0.0073
2022-10-27 2022-06-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 345,323 -37,034 -9.69 81,373 18.62 0.0106
2022-08-15 2022-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 345,323 -37,034 81,373 0.0106
2022-10-27 2022-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 382,357 232,759 155.59 68,599 112.22 0.0093
2022-05-13 2022-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 382,357 232,759 68,599 0.0093
2022-02-14 2021-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 149,598 40,350 36.93 32,325 60.30 0.0040
2021-11-15 2021-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 109,248 -20,742 -15.96 20,165 -13.54 0.0027
2021-08-23 2021-06-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 129,990 92,346 245.31 23,323 270.32 0.0031
2021-08-16 2021-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 129,990 92,346 23,323 0.0006
2021-05-17 2021-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 37,644 -8,391 -18.23 6,298 -9.87 0.0009
2021-02-16 2020-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 46,035 21,580 88.24 6,988 183.03 0.0011
2020-11-13 2020-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 24,455 7,525 44.45 2,469 20.50 0.0005
2020-08-14 2020-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 16,930 -11,301 -40.03 2,049 -23.46 0.0005
2020-05-26 2020-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 28,231 -125,654 -81.65 2,677 -80.25 0.0007
2020-05-15 2020-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 28,231 -125,654 2,677 205.6494
2020-02-14 2019-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 153,885 91,200 145.49 13,555 171.15 0.0032
2019-11-14 2019-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 62,685 -88,767 -58.61 4,999 -57.72 0.0013
2019-08-14 2019-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 151,452 -9,305 -5.79 11,823 -37.34 0.0031
2019-05-15 2019-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 160,757 -27,789 -14.74 18,869 -8.10 0.0053
2019-02-14 2018-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 188,546 -55,082 -22.61 20,531 -34.10 0.0061
2019-04-23 2018-09-30 13F/A-2 UNITED THERAPEUTICS CORP DEL COM 91307C102 243,628 21,129 9.50 31,154 23.75 0.0078
2018-11-20 2018-09-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 243,628 0 31,154 0.0078
2018-11-14 2018-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 243,628 21,129 31,154
2019-04-23 2018-06-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 222,499 67,060 43.14 25,175 44.15 0.0068
2018-08-14 2018-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 222,499 67,060 25,175
2019-04-23 2018-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 155,439 -18,411 -10.59 17,465 -32.10 0.0048
2018-05-14 2018-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 155,439 -18,411 17,465
2019-04-23 2017-12-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 173,850 -342,588 -66.34 25,721 -57.50 0.0070
2018-02-14 2017-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 173,850 -342,588 25,721
2017-11-14 2017-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 516,438 -146,511 -22.10 60,522 -29.63 0.0181
2017-08-11 2017-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 662,949 12,753 1.96 86,004 -2.29 0.0260
2017-05-22 2017-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 650,196 195,147 42.88 88,023 34.86 0.0271
2017-05-12 2017-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 650,196 88,023
2017-02-22 2016-12-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 455,049 92,633 25.56 65,269 52.52 0.0214
2017-02-13 2016-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 455,049 65,269
2016-11-10 2016-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 362,416 -33,758 -8.52 42,794 1.98 0.0146
2016-08-12 2016-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 396,174 56,510 16.64 41,963 10.88 0.0152
2016-05-12 2016-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 339,664 17,499 5.43 37,847 -24.99 0.0146
2016-02-09 2015-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 322,165 24,130 8.10 50,455 28.99 0.0183
2016-02-08 2015-09-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 298,035 12,919 4.53 39,115 -21.13 0.0145
2015-11-09 2015-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 298,035 39,115
2015-08-12 2015-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 285,116 -25,947 -8.34 49,596 -7.54 0.0172
2015-05-14 2015-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 311,063 -15,928 -4.87 53,638 26.68 0.0198
2015-02-13 2014-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 326,991 89,203 37.51 42,341 38.41 0.0155
2014-12-16 2014-09-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 237,788 -64,636 -21.37 30,591 7.57 0.0118
2014-11-14 2014-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 237,788 30,591
2014-05-13 2014-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 302,424 101,805 50.75 28,438 25.35 0.0119
2014-02-13 2013-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 200,619 19,434 10.73 22,687 58.79 0.0097
2013-11-13 2013-09-30 13F UNITED THERAPEUTICS CORP DE COM 91307C102 181,185 5,833 3.33 14,287 23.77 0.0068
2013-08-08 2013-06-30 13F UNITED THERAPEUTICS CORP DE COM 91307C102 175,352 175,352 11,543 0.0058
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.